# Filing Detail

Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-23-040115
Filing Date
2023-11-09
Accepted
2023-11-09 17:16:22
Documents
69
Period of Report
2023-09-30

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 |  | form10-q.htm iXBRL | 10-Q | 1329235
2 |  | ex10-3.htm | EX-10.3 | 5462
3 |  | ex10-5.htm | EX-10.5 | 1775
4 |  | ex31-1.htm | EX-31.1 | 17596
5 |  | ex31-2.htm | EX-31.2 | 18358
6 |  | ex32-1.htm | EX-32.1 | 7056
7 |  | ex32-2.htm | EX-32.2 | 7285
8 |  | ex10-3_001.jpg | GRAPHIC | 230762
9 |  | ex10-3_002.jpg | GRAPHIC | 177143
10 |  | ex10-3_003.jpg | GRAPHIC | 213877
11 |  | ex10-3_004.jpg | GRAPHIC | 164552
12 |  | ex10-3_005.jpg | GRAPHIC | 63041
13 |  | ex10-5_001.jpg | GRAPHIC | 218308
14 |  | ex10-5_002.jpg | GRAPHIC | 94081
| Complete submission text file | 0001493152-23-040115.txt |  | 8226600

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
15 | XBRL SCHEMA FILE | lixt-20230930.xsd | EX-101.SCH | 47757
16 | XBRL CALCULATION FILE | lixt-20230930_cal.xml | EX-101.CAL | 33898
17 | XBRL DEFINITION FILE | lixt-20230930_def.xml | EX-101.DEF | 226090
18 | XBRL LABEL FILE | lixt-20230930_lab.xml | EX-101.LAB | 405161
19 | XBRL PRESENTATION FILE | lixt-20230930_pre.xml | EX-101.PRE | 315493
63 | EXTRACTED XBRL INSTANCE DOCUMENT | form10-q_htm.xml | XML | 1092529

Mailing Address 248 ROUTE 25A NO. 2 EAST SETAUKET NY 11733
Business Address 248 ROUTE 25A NO. 2 EAST SETAUKET NY 11733 310 203 2902
LIXTE BIOTECHNOLOGY HOLDINGS, INC. (Filer) CIK: 0001335105 (see all company filings)

EIN.: 202903526 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39717 | Film No.: 231393770
SIC: 2834 Pharmaceutical Preparations